Successful treatment of AIDS-related pulmonary Kaposi's sarcoma with liposomal daunorubicin.
We report a 35 year old male, human immunodeficiency virus (HIV)-infected patient with acquired immune deficiency syndrome (AIDS), who presented with rapidly progressive pulmonary Kaposi's sarcoma. The tumour regressed with treatment with liposomal daunorubicin and remained in partial remission until the patient died 12 months later from complications of HIV infection. Liposomal daunorubicin may be a safe and effective alternative to the treatment protocols in current use for pulmonary Kaposi's sarcoma.
Schürmann
D
D
2nd Dept of Internal Medicine (Dept for Infectious Diseases), Rudolf Virchow University Hospital, Freie Universität Berlin, Germany.
Dormann
A
A
Grünewald
T
T
Ruf
B
B
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D003630:Daunorubicin / Q000008:administration & dosage*; D006801:Humans; D008081:Liposomes; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D011859:Radiography; D012514:Sarcoma, Kaposi / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology
D008081:Liposomes; D003630:Daunorubicin